Skip to main content
Please join Noticeboard
You are offline
Good Health and Well-being
May 10, 2021

'Have to invest in scaling up now': Serum Institute defends Covishield pricing in private hospitals

Kasi Rajan K Good Health and Well-being

Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of ₹600 per dose and at ₹400 for state governments and any new contract by the central governmentThe Serum Institute of India (SII) today issued a clarification on the pricing of the covid-19 vaccine Covishield. SII said that the initial prices of the COVID-19 vaccine were low globally due to advance funding but it will need investment in scaling up the vaccine production now.Serum Institute of India, which makes the most used Covid-19 vaccine in the country, defended pricing Covishield vaccine at 1.5 times the initial rate."Only a limited portion of SII's volume will be sold to private at Rs600 per dose. The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat covid-19 and other life-threatening diseases," according to a statement from the SII.

View Source

Discussion (0)

No comments yet

This notice is currently unavailable

It may have been set to private or is under review

This notice has expired

This notice has been removed

The content is no longer available

'Have to invest in scaling up now': Serum Institute defends Covishield pricing in private hospitals

Good Health and Well-being

Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of ₹600 per dose and at ₹400 for state governments and any new contract by the central governmentThe Serum Institute of India (SII) today issued a clarification on the pricing of the covid-19 vaccine Covishield. SII said that the initial prices of the COVID-19 vaccine were low globally due to advance funding but it will need investment in scaling up the vaccine production now.Serum Institute of India, which makes the most used Covid-19 vaccine in the country, defended pricing Covishield vaccine at 1.5 times the initial rate."Only a limited portion of SII's volume will be sold to private at Rs600 per dose. The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat covid-19 and other life-threatening diseases," according to a statement from the SII.

Recent Searches

Recent Noticeboards

No results found

Try a different search term

Something went wrong

No notices yet

No notices match these filters

Couldn't load notices

You're all caught up 🎉

Message

Create 3 Noticeboards to earn this Silver level Community Champion Badge.

View all badges that you can earn

You're only a minute from joining in

Discover Noticeboards

Report Content

Please tell us why you are reporting this content.